ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 6607933

Human auto-antiidiotypes regulating T cell-mediated reactivity to tetanus toxoid.

Saxon A and 1 other. J Clin Invest, 1984. Cited by 32 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Human auto-antiidiotypes regulating T cell-mediated reactivity to tetanus toxoid. Papers, record 6607933. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6607933

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human auto-antiidiotypes regulating T cell-mediated reactivity to tetanus toxoid.
PubMed
Journal
J Clin Invest
PubMed
Year
1984
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
0.95
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Saxon AA
2Barnett EE

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AutoantibodiesMajor topic
Immunoglobulin IdiotypesMajor topic
T-LymphocytesMajor topic
Tetanus ToxoidMajor topic
Adult
Blood
Cells, Cultured
Humans
Hypersensitivity, Delayed
Immunization
Immunoglobulin Fab Fragments
Middle Aged

Source PubMed

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI-00326NIAID NIH HHSUnited StatesPubMedPubMed
AI-15251NIAID NIH HHSUnited StatesR01AI015251PubMed and NIHNIH RePORTER
CA-12800NCI NIH HHSUnited StatesP01CA012800PubMed and NIHNIH RePORTER
R21AI015251NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,347,697Regulation of antibody formation by serum antibody. I. Removal of specific antibody by means of immunoadsorption.J Exp Med1969https://conductscience.org/library/papers/5347697PubMed
26,183,357Common idiotypic determinant associated with human antibodies to hepatitis B surface antigen.J Immunol1983https://conductscience.org/library/papers/6183357PubMed
36,601,133Presence of circulating anti-idiotype-bearing cells after booster immunization with tetanus toxoid (TT) and inhibition of anti-TT antibody synthesis by auto-anti-idiotypic antibody.J Immunol1983https://conductscience.org/library/papers/6601133PubMed
414,427,334Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds.Arch Biochem Biophys1960https://conductscience.org/library/papers/14427334PubMed
51,085,784Single step separation of human T and B cells using AET treated srbc rosettes.J Immunol Methods1976https://conductscience.org/library/papers/1085784PubMed
6305,008Antigen-antibody complexes elicit anti-idiotypic antibodies to self-idiotopes.Nature1978https://conductscience.org/library/papers/305008PubMed
7701,806Anti-idiotypic antisera in man. I. Production and immunochemical characterization of anti-idiotypic antisera to human antitetanus antibodies.J Immunol1978https://conductscience.org/library/papers/701806PubMed
8310,845Reduced in vitro production of anti-tetanus toxoid antibody after repeated in vivo immunization with tetanus toxoid.J Immunol1979https://conductscience.org/library/papers/310845PubMed
9312,903
Production of auto-anti-idiotypic antibody during the normal immune response to TNP-ficoll. I. Occurrence in AKR/J and BALB/c mice of hapten-augmentable, anti-TNP plaque-forming cells and their accelerated appearance in recipients of immune spleen cells.
J Exp Med1979https://conductscience.org/library/papers/312903PubMed
10314,964Characterization and measurement of anti-IgG antibodies in human sera by radioimmunoassay (RIA).J Immunol Methods1979https://conductscience.org/library/papers/314964PubMed

1 to 10 of 39

See all 39 references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
39,830,669A Preliminary Study to Evaluate the Immune Response to a Booster Dose of the Adult Tetanus-Diphtheria Vaccine (Td) Available in Iran.Iran J Pharm Res2024https://conductscience.org/library/papers/39830669PubMed
8,467,560Lower antibody response to tetanus toxoid associated with higher auto-anti-idiotypic antibody in old compared with young humans.Clin Exp Immunol1993https://conductscience.org/library/papers/8467560PubMed
8,195,318Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation.J Clin Immunol1994https://conductscience.org/library/papers/8195318PubMed
6,210,306Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.J Clin Invest1984https://conductscience.org/library/papers/6210306PubMed
3,558,824Crossreactivity and inheritance of idiotypes restricted to human anti-tetanus toxoid antibodies.J Clin Invest1987https://conductscience.org/library/papers/3558824PubMed
3,492,316Anti-idiotypes to anti-Lolp I (Rye) antibodies in allergic and non-allergic individuals. Influence of immunotherapy.Clin Exp Immunol1986https://conductscience.org/library/papers/3492316PubMed
2,958,189The effect of La(SSB) on PWM-induced immunoglobulin synthesis by anti-La(SSB) positive SLE patients and healthy controls.Clin Exp Immunol1987https://conductscience.org/library/papers/2958189PubMed
2,786,203Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2786203PubMed
2,525,435Concomitant augmentation of CD4+ CD45R+ suppressor/inducer subset and diminution of CD4+ CDw29+ helper/inducer subset during rush hyposensitization in hymenoptera venom allergy.Clin Exp Immunol1989https://conductscience.org/library/papers/2525435PubMed
2,372,990Detection of auto-anti-idiotypic antibodies to Lol p I (rye I) IgE antibodies in human sera by the use of murine idiotypes: levels in atopic and non-atopic subjects and effects of immunotherapy.Clin Exp Immunol1990https://conductscience.org/library/papers/2372990PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6607933

GET https://conductscience.org/api/papers/v1/6607933/references?page=2

API referenceFor AI assistants